Bill Commons

MN SF 2645

died on adjournment

Formulary Committee members with a potential conflict of interest participation in committee communications and discussions authorization provision, public comment process for recommendations to the Formulary Committee development by the commissioner of human services requirement provision, and Minnesota Rare Disease Advisory Council expertise sought by the Formulary Committee requirement provision

Minnesota · 2025-2026 · upper

Introduced
2025-03-17
Status date
Latest action
2025-03-17 — Referred to Health and Human Services
Bill type
bill
Last updated

Subjects

Sponsors

  • Boldonprimary
  • Lieskecosponsor
  • Kupeccosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-03-17

    Introduction and first reading

    introduction

  2. 2025-03-17

    Referred to Health and Human Services

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:48.331508Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=SF 2645. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.